Literature DB >> 2507376

Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men.

J D Bagdade1, P V Subbaiah.   

Abstract

To determine whether compositional abnormalities are present in high-density lipoprotein (HDL) in patients with insulin-dependent diabetes mellitus (IDDM) that might negate its putatively protective cardiovascular effects, we studied the plasma lipoproteins of 12 men with varying degrees of clinical control (mean fasting glucose 193 +/- 10 mg/dl, mean glycoalbumin greater than 73% above control mean). The diabetic patients' basal plasma triglyceride, total- and free- (unesterified) cholesterol, HDL cholesterol (HDL-chol), and apolipoprotein AI, AII, and B concentrations were similar to those of control subjects, but the free-cholesterol-to-lecithin ratio, a new index of cardiovascular disease risk, was significantly increased in their plasma (0.97 +/- 0.14 vs. 0.88 +/- 0.07, P less than .02) and their very-low-density lipoprotein (VLDL)-low-density lipoprotein (LDL) subfraction (1.50 +/- 0.51 vs. 1.08 +/- 0.15, P less than .005). Although HDL2-chol was similar in diabetic and control groups, the HDL2-chol-to-free-cholesterol ratio (diabetic vs. control, 4.64 +/- 1.7 vs. 1.96 +/- 1.0 mumol/ml, P less than .025) and the sphingomyelin-to-lecithin ratio (0.23 +/- 0.08 vs. 0.20 +/- 0.09, P less than .025) were both significantly increased in the IDDM group. HDL3-chol was higher in the IDDM than in the control subjects (diabetic vs. control, 38.6 +/- 5.2 vs. 32.7 +/- 2.7 mg/dl, P less than .005). In contrast to whole plasma and the VLDL + LDL subfraction, the free-cholesterol-to-lecithin ratio of IDDM and control HDL subfractions were similar.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507376     DOI: 10.2337/diab.38.10.1226

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

Review 1.  Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors:  P H Winocour
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

2.  Marine lipids normalize cholesteryl ester transfer in IDDM.

Authors:  J D Bagdade; M Ritter; P V Subbaiah
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

3.  Reference distributions for apolipoproteins AI and B and B/AI ratios: comparison of a large cohort to the world's literature.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Thomas B Ledue; Santica Marcovina; Olga Navolotskaia
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

4.  Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.

Authors:  E Manzato; A Zambon; S Zambon; R Nosadini; A Doria; R Marin; G Crepaldi
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

5.  Abnormal distribution of VLDL subfractions in type 1 (insulin-dependent) diabetic patients: could plasma lipase activities play a role?

Authors:  L Patti; G Romano; L Di Marino; G Annuzzi; M Mancini; G Riccardi; A A Rivellese
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

6.  Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  S S Soedamah-Muthu; Y-F Chang; J Otvos; R W Evans; T J Orchard
Journal:  Diabetologia       Date:  2003-05-13       Impact factor: 10.122

7.  Lecithin:cholesterol acyltransferase activity and high-density lipoprotein subfraction composition in type 1 diabetic patients with improving metabolic control.

Authors:  M J Weight; H S Coetzee; C M Smuts; M P Marais; J S Maritz; F S Hough; A J Benadé; J J Taljaard
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

8.  Insulin excess counteracts the effects of HDL on intracellular sterol accumulation in cultured human skin fibroblasts.

Authors:  R L Brazg; E L Bierman
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

9.  Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study).

Authors:  Ville-Petteri Mäkinen; Tuulia Tynkkynen; Pasi Soininen; Carol Forsblom; Tomi Peltola; Antti J Kangas; Per-Henrik Groop; Mika Ala-Korpela
Journal:  Metabolomics       Date:  2011-08-05       Impact factor: 4.290

Review 10.  Sphingomyelin in high-density lipoproteins: structural role and biological function.

Authors:  Roberto Martínez-Beamonte; Jose M Lou-Bonafonte; María V Martínez-Gracia; Jesús Osada
Journal:  Int J Mol Sci       Date:  2013-04-09       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.